Health Care Select Sector SPDR (XLV)

At A Glance

You hold XLV in 0 portfolios

Price

128.04USD

-3.29 -2.51%

4:00pm EDT

YTD Return (Cumulative)

-9.12%

Classification

Health/Biotech

3 Year Return (Annualized)

15.49%

52 Week High

$143.42

52 Week Low

$120.61

Lipper Leader Profile (Overall)

Total Return

Consistent Return

Capital Preservation

Low Expense

Tax Efficiency(U.S. only)

Holdings Diversification »

Asset Class

	100% Stocks
	0% Cash

Key Statistics

Total Net Assets	$36.91B
Total Stock Holdings	66
Total Bond Holdings	0
% Foreign Stocks	0%
Portfolio Turnover Rate	4%

Fund Characteristics

XLV's equity holdings have an average USD dollar-weighted market cap of $203.69 billion, a weighted average price/earnings of 29.6x, and an average price/book of 8.3x.

Geographic Exposure

Country Exposure

3% Ireland

97% Remainder

Top Holdings (as of Mar 31, 2022)

Market Cap

89%	Mega Cap
11%	Large Cap

Concentration

52.6% concentration in Top 10 Holdings

20.1% concentration in next 10 holdings

27.1% concentration in the remainder of the holdings

Top 10 Holdings		% of Assets (Change vs 1Q Ago)	Recent News
1	UnitedHealth Group Inc ORD UNH	9.2% (+2.6%) (-9.8%) (+20.0%)	13 (13) News Stories BRIEF-Soros Fund Management Ups Share Stake In Airbnb, Alphabet; Dissoves In GM, Uber, Peloton & UnitedHealth 2022-05-13 21:30:31 BRIEF-UnitedHealthcare Selected By State Of Missouri To Serve Medicaid Beneficiaries 2022-05-12 13:19:59 Arkansas sues drugmakers, pharmacy benefit managers over insulin costs 2022-05-11 17:22:01 CORRECTED-U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 16:14:57 UPDATE 3-Health insurer Cigna boosts forecast as COVID costs recede 2022-05-06 14:53:57 UPDATE 2-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 12:14:42 U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 11:00:00 UPDATE 1-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 10:35:49 Deals of the day-Mergers and acquisitions 2022-04-25 20:01:12 UPDATE 2-UnitedHealth to sell Change Healthcare's claims business for $2.2 bln 2022-04-25 15:49:42 Deals of the day-Mergers and acquisitions 2022-04-25 13:58:51 UPDATE 1-UnitedHealth to sell Change Healthcare's claims business for $2.2 bln 2022-04-25 13:57:39 UnitedHealth to sell Change Healthcare's claims business for $2.2 bln 2022-04-25 13:28:42
2	Johnson & Johnson ORD JNJ	8.9% (+6.9%) (-2.8%) (+4.9%)	20 (20) News Stories INSIGHT-When Africans asked for COVID shots, they didn't get them. Now they don't want them 2022-05-18 07:00:05 What you need to know about the coronavirus right now 2022-05-13 12:12:20 UPDATE 4-S.Africa's president says agencies should order Africa-made vaccines 2022-05-12 16:50:08 UPDATE 2-S.Africa's president says agencies should order Africa-made vaccines 2022-05-12 15:46:33 J&J appoints consumer health head Thibaut Mongon to CEO of spun-off business 2022-05-11 11:16:28 BRIEF-Johnson & Johnson Appoints Thibaut Mongon As CEO Designate Of Planned New Consumer Health Company 2022-05-11 10:32:49 J&J appoints consumer health head Thibaut Mongon to CEO of spun-off business 2022-05-11 10:30:03 UPDATE 2-Pharmacy chains should pay $878 mln for opioid epidemic role, Ohio counties say 2022-05-10 18:32:23 UPDATE 1-Pharmacy chains should pay $878 mln for opioid epidemic role, Ohio counties say 2022-05-10 16:05:09 WHO, Gavi not planning COVID vaccine buys from S.Africa's Aspen 2022-05-09 12:37:56 COVID vaccine makers shift focus to boosters 2022-05-09 10:00:00 BRIEF-Janssen Discontinues Collaboration And License Agreements With Bavarian Nordic In Hepatitis B And Human Papillomavirus 2022-05-09 06:09:09 COVID SCIENCE-Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from variants 2022-05-06 17:13:43 What you need to know about the coronavirus right now 2022-05-06 12:33:52 PRESS DIGEST- New York Times business news - May 6 2022-05-06 07:11:05 UPDATE 3-U.S. limits use of J&J's COVID vaccine on blood clot risks 2022-05-06 00:01:37 BRIEF-J&J Updates U.S. Covid-19 Vaccine Fact Sheet To Increase Awareness On Risk Of TTS 2022-05-05 23:26:24 UPDATE 2-U.S. limits use of J&J's COVID vaccine on blood clot risks 2022-05-05 22:32:04 UPDATE 4-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 14:55:44 UPDATE 3-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:50:14
3	Pfizer Inc ORD PFE	5.6% (+3.3%) (+3.2%) (+28.2%)	20 (20) News Stories REFILE-U.S. to study whether longer Paxlovid course needed to combat reinfections 2022-05-18 17:04:21 UPDATE 1-As COVID cases rise, U.S. health officials mull widening additional booster eligibility 2022-05-18 16:20:14 BRIEF-EMA Starts Evaluating Application For Use Of Booster Dose Of Comirnaty In Children Aged 5-11 Years 2022-05-18 14:29:41 INSIGHT-When Africans asked for COVID shots, they didn't get them. Now they don't want them 2022-05-18 07:00:05 From storage to transport, hurdles to getting COVID vaccine to N.Koreans 2022-05-18 06:56:44 UPDATE 3-As U.S. COVID-19 cases rise, so does demand for antivirals 2022-05-17 22:12:15 UPDATE 2-U.S. says use of Pfizer's COVID-19 antiviral up 315% 2022-05-17 20:09:35 U.S. use of Pfizer's COVID antiviral Paxlovid up 315% -HHS 2022-05-17 18:40:02 UPDATE 3-U.S. FDA authorizes Pfizer's COVID booster shot for young children 2022-05-17 16:12:10 BRIEF-Pfizer Says To Date, 4,500 Children 5 Through 11 Years Of Age Have Participated In Companies' Covid-19 Vaccine Clinical Trial 2022-05-17 15:42:54 UPDATE 2-U.S. FDA clears Pfizer's COVID booster shot for young children 2022-05-17 14:51:31 UPDATE 1-U.S. FDA authorizes Pfizer's COVID booster shot for young children 2022-05-17 14:24:40 U.S. FDA authorizes Pfizer's COVID booster shot for young children 2022-05-17 14:17:53 UPDATE 2-AstraZeneca boosts COVID portfolio with RQ Bio deal 2022-05-17 08:31:24 UPDATE 1-AstraZeneca bolsters COVID therapeutics with RQ Bio deal 2022-05-17 06:37:06 UPDATE 3-FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT 2022-05-16 22:35:36 UPDATE 2-FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT 2022-05-16 21:44:18 UPDATE 1-FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT 2022-05-16 20:30:57 FDA to authorize Pfizer's COVID booster shot for younger kids soon -NYT 2022-05-16 20:07:17 BRIEF-The U.S. FDA Is Expected As Early As Tuesday To Authorize A Booster Shot Of The Pfizer-Biontech Vaccine For Children 5 To 11 - NYT 2022-05-16 19:59:26
4	Abbvie Inc ORD ABBV.K	5.5% (+6.1%) (-1.2%) (+32.1%)	16 (16) News Stories BRIEF-Berkshire Hathaway Dissolves Share Stake In Abbvie, Bristol-Myers; Takes Share Stake in Paramount Global, Ally Financial 2022-05-16 22:02:18 BRIEF-Abbvie Inc - Upadacitinib (RINVOQ®) Achieved Clinical Remission And Endoscopic Response At One Year In Phase 3 Maintenance Study In Patients With Crohn's Disease 2022-05-11 12:50:57 Pfizer to pay $11.6 billion for Biohaven to tap migraine market 2022-05-10 18:06:14 UPDATE 4-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 14:55:44 UPDATE 3-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:50:14 UPDATE 2-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:32:29 UPDATE 1-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:17:33 Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:06:23 BRIEF-Abbvie Says Triple Combination Drug For Cystic Fibrosis Fails To Meet Co's Criteria 2022-04-29 13:36:17 BRIEF-Abbvie Reports Qtrly Net Revenue $13.54 Billion, Up 4.1% on GAAP basis 2022-04-29 11:51:33 AbbVie misses quarterly sales estimates as Humira rivals bite 2022-04-29 11:48:43 BRIEF-Hungary Richter Says Canada Approves Vraylar For Treatment Of Bipolar Disorder 2022-04-27 11:45:39 UPDATE 2-Walgreens, Teva accused of fueling opioid addiction in quest for new markets 2022-04-25 23:10:36 Walgreens, Teva face San Francisco trial over opioid epidemic 2022-04-25 13:08:41 Walgreens, Teva face San Francisco trial over opioid epidemic 2022-04-25 13:00:00 BRIEF-Dragonfly Announces Multi-Target Expansion Of Research Collaboration With AbbVie 2022-04-20 12:21:56
5	Thermo Fisher Scientific Inc ORD TMO	4.5% (+0.8%) (-6.2%) (+22.0%)	4 (4) News Stories BRIEF-Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions To Streamline Biologics Development And Compliance 2022-05-10 12:09:20 UPDATE 1-Sartorius sticks to 2022 outlook despite rising costs, Ukraine 2022-04-21 06:25:56 Sartorius confirms 2022 outlook as pandemic effects, order intake normalise 2022-04-21 05:35:46 BRIEF-Thermo Fisher Scientific Opens Bioprocessing Manufacturing Site In Ogden, Utah 2022-04-20 12:58:02
6	Eli Lilly and Co ORD LLY	4.4% (+22.7%) (+2.9%) (+54.9%)	12 (12) News Stories UPDATE 1-U.S. FDA approves Eli Lilly's treatment for type 2 diabetes 2022-05-13 19:59:45 U.S. FDA approves Eli Lilly's treatment for type 2 diabetes 2022-05-13 19:12:21 BRIEF-FDA Approves Novel, Dual-Targeted Treatment For Type 2 Diabetes 2022-05-13 19:04:55 Arkansas sues drugmakers, pharmacy benefit managers over insulin costs 2022-05-11 17:22:01 Pfizer to pay $11.6 billion for Biohaven to tap migraine market 2022-05-10 18:06:14 CORRECTED-U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 16:14:57 U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 11:00:00 BRIEF-Eli Lilly CEO David Ricks Says Fortunately Russia Is Not A Big Portfolio For Us- CNBC Interview 2022-04-28 11:30:52 BRIEF-Lilly's Tirzepatide Delivered Up To 22.5% Weight Loss In Adults With Obesity Or Overweight In Surmount-1 2022-04-28 10:22:59 UPDATE 1-Amgen says IRS seeks billions in back taxes, shares fall 4% 2022-04-27 20:52:29 Amgen says IRS seeks another $5.1 billion in back taxes 2022-04-27 20:26:56 UPDATE 3-Biogen pulls application for Alzheimer's drug in Europe 2022-04-22 15:39:04
7	Abbott Laboratories ORD ABT	4.0% (-7.4%) (-6.6%) (-2.1%)	20 (20) News Stories UPDATE 3-U.S. Democrats unveil bill to address baby formula shortage 2022-05-17 20:34:10 TIMELINE-Baby formula crunch in U.S. forces scramble to boost supplies 2022-05-17 17:13:43 UPDATE 1-U.S. Democrats unveil bill to address baby formula shortage 2022-05-17 14:44:25 WRAPUP 1-Baby formula makers ramp up U.S. supplies to tackle shortage 2022-05-17 08:04:50 PRESS DIGEST-New York Times business news - May 17 2022-05-17 04:27:44 Enfamil maker Reckitt cranks up operations to put baby formula on U.S shelves 2022-05-17 02:00:00 UPDATE 5-U.S. to allow baby formula imports amid nationwide shortage 2022-05-17 00:25:01 Reckitt Benckiser says it is working to boost baby formula output amid U.S. shortage 2022-05-16 22:57:24 UPDATE 3-Abbott, FDA reach agreement to reopen baby formula facility in Michigan 2022-05-16 22:54:46 BRIEF-FDA Encourages Importation Of Safe Infant Formula And Other Flexibilities To Further Increase Availability 2022-05-16 22:43:08 BRIEF-FDA Issues Statement Regarding Baby Formula Imports 2022-05-16 22:25:02 UPDATE 4-U.S. eyes baby formula imports amid nationwide shortage 2022-05-16 21:29:36 UPDATE 1-Abbott, FDA enter deal over reopening of baby formula facility in Michigan 2022-05-16 20:59:43 Abbott, FDA enter agreement over reopening of baby formula facility in Michigan 2022-05-16 20:35:06 BRIEF-Abbott Says After FDA Approval, Co Could Restart Michigan Site Within Two Weeks 2022-05-16 20:29:47 UPDATE 3-U.S. eyes baby formula imports amid nationwide shortage 2022-05-16 18:11:24 Biden says baby formula supplies to increase 'significantly' in weeks 2022-05-13 19:51:36 Imported infant formula could help lift U.S. supply in weeks -FDA chief 2022-05-13 17:13:44 U.S. CDC closes investigation on Abbott's infant formula 2022-05-13 16:30:07 UPDATE 3-U.S. House will investigate baby formula shortage 2022-05-13 15:32:54
8	Merck & Co Inc ORD MRK	4.0% (+20.4%) (+7.6%) (+17.2%)	20 (20) News Stories UPDATE 3-As U.S. COVID-19 cases rise, so does demand for antivirals 2022-05-17 22:12:15 UPDATE 2-U.S. says use of Pfizer's COVID-19 antiviral up 315% 2022-05-17 20:09:35 U.S. use of Pfizer's COVID antiviral Paxlovid up 315% -HHS 2022-05-17 18:40:02 BRIEF-Adage Capital Partners Cuts In Tesla, Merck; Ups In Dupont, Verizon & Colgate 2022-05-16 13:51:32 Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries 2022-05-12 14:00:00 MORNING BID-Still too hot 2022-05-12 06:54:29 RPT-New class of cancer drugs down, not out, after Roche trial setback - analysts 2022-05-12 06:00:00 New class of cancer drugs down, not out, after Roche trial setback - analysts 2022-05-11 18:28:44 Pfizer's $11.6 billion Biohaven buy could spark more biotech deals 2022-05-11 17:18:02 UPDATE 2-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 07:39:22 UPDATE 1-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 06:16:46 BRIEF-Biocytogen Enters into Antibody Agreement with Merck 2022-04-29 12:08:47 COVID SCIENCE-Mental health issues in kids rose during pandemic; awareness and use of COVID treatments is low 2022-04-28 18:54:47 BRIEF-Merck Reports Q1 Non-Gaap Earnings of $2.14 Per Share 2022-04-28 10:41:30 Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs 2022-04-28 10:41:17 Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs 2022-04-28 10:30:00 UPDATE 1-EU estimates up to 80% of population has had COVID 2022-04-27 13:11:43 EU looks at ramping up COVID vaccinations of kids, developing antivirals 2022-04-27 12:33:40 UPDATE 1-U.S. to widen COVID antiviral pill distribution 2022-04-26 12:35:46 WHO backs Pfizer's oral COVID therapy for high-risk patients 2022-04-21 22:01:00
9	Danaher Corp ORD DHR	3.6% (-7.0%) (-11.2%) (-0.4%)	2 (2) News Stories BRIEF-Danaher Joins Bespoke Gene Therapy Consortium For Rare Diseases 2022-05-12 20:31:27 BRIEF-Danaher Reports First Quarter 2022 Results 2022-04-21 10:16:42
10	Bristol-Myers Squibb Co ORD BMY	3.1% (+15.7%) (+1.2%) (+19.2%)	14 (14) News Stories BRIEF-Berkshire Hathaway Dissolves Share Stake In Abbvie, Bristol-Myers; Takes Share Stake in Paramount Global, Ally Financial 2022-05-16 22:02:18 BRIEF-Bristol Myers Squibb Says Phase 3 Checkmate -901 Trial Did Not Meet Primary Endpoint 2022-05-16 11:08:14 BRIEF-Lotte Corp Buys Bristol Myers Squibb's Manufacturing Facility In New York At $160 Million 2022-05-13 08:30:58 BRIEF-New Two-Year Deucravacitinib Data Reinforce Durable Efficacy And Consistent Safety Profile In Treatment Of Moderate To Severe Plaque Psoriasis 2022-05-12 10:59:47 UPDATE 2-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 07:39:22 UPDATE 1-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 06:16:46 BRIEF-Evotec And Bristol Myers Squibb Extend And Expand Strategic Partnership 2022-05-10 14:33:13 Bristol Myers 1st-quarter sales up on Eliquis, Opdivo 2022-04-29 11:04:07 BRIEF-Bristol-Myers Squibb Reports QTRLY Revenues Of $11.6 Billion 2022-04-29 11:02:02 Bristol Myers 1st-quarter sales up on Eliquis, Opdivo 2022-04-29 10:59:00 UPDATE 2-FDA approves Bristol Myers' oral heart disease drug 2022-04-29 02:09:12 UPDATE 1-FDA approves Bristol Myers' heart disease drug 2022-04-29 01:06:18 BRIEF-EDP Renewables, Bristol Myers Squibb Execute Power Purchase Agreement For The Cattlemen Solar Park 2022-04-21 11:11:07 BRIEF-Bristol-Myers - GAAP And Non-GAAP Earnings Per Share Is Expected To Include Net Negative Impact Of Approximately $0.10 Per Share During Q1 2022 2022-04-18 21:02:59
11	Medtronic PLC ORD MDT	2.9% (+3.0%) (-6.0%) (-15.6%)	5 (5) News Stories BRIEF-U.S. FTC Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act For Intersect ENT Merger With Medtronic 2022-05-09 21:36:28 BRIEF-Titan Medical Announces Purchase Order From Medtronic 2022-05-03 12:04:19 BRIEF-Medtronic PLC Says Unit Medtronic Global Holdings S.C.A. Entered Into Term Loan Agreement 2022-05-02 12:25:13 BRIEF-FDA Says Medtronic Recalls Harmony Delivery Catheter, Part Of Transcatheter Pulmonary Valve (Tpv) System, For Risk Of Capsule Break During Use 2022-04-26 15:33:33 BRIEF-Medtronic Names New Chief Scientific, Medical, And Regulatory Officer 2022-04-25 20:42:32
12	Amgen Inc ORD AMGN.O	2.6% (+9.6%) (-3.2%) (-2.8%)	7 (7) News Stories Pfizer to pay $11.6 billion for Biohaven to tap migraine market 2022-05-10 18:06:14 PRESS DIGEST- Wall Street Journal - April 28 2022-04-28 06:07:48 UPDATE 1-Amgen says IRS seeks billions in back taxes, shares fall 4% 2022-04-27 20:52:29 BRIEF-Amgen Reports Q1 Financial Results 2022-04-27 20:41:04 Amgen says IRS seeks another $5.1 billion in back taxes 2022-04-27 20:34:38 Amgen says IRS seeks another $5.1 billion in back taxes 2022-04-27 20:26:56 BRIEF-Amgen Reports Results From Two Open Label Extension Studies Of Repatha 2022-04-27 13:20:28
13	CVS Health Corp ORD CVS	2.5% (-4.4%) (-6.8%) (+12.2%)	20 (20) News Stories TIMELINE-Baby formula crunch in U.S. forces scramble to boost supplies 2022-05-17 17:13:43 UPDATE 4-Biden presses companies on infant formula, FDA eyes more imports 2022-05-13 00:31:24 UPDATE 3-Biden presses companies on infant formula, FDA eyes more imports 2022-05-12 20:21:41 UPDATE 2-Biden to discuss infant formula shortage with companies 2022-05-12 17:53:41 UPDATE 1-Biden to get update on U.S. infant formula supplies on Thursday 2022-05-12 15:10:12 UPDATE 2-U.S. lawmakers to examine infant formula shortage 2022-05-11 22:03:41 UPDATE 1-U.S. Senate confirms Bedoya, giving Democrats FTC control 2022-05-11 19:32:53 UPDATE 1-U.S. lawmakers to examine infant formula shortage 2022-05-11 17:58:23 Arkansas sues drugmakers, pharmacy benefit managers over insulin costs 2022-05-11 17:22:01 U.S. House to hold hearing on infant formula shortage 2022-05-11 16:22:51 UPDATE 2-Pharmacy chains should pay $878 mln for opioid epidemic role, Ohio counties say 2022-05-10 18:32:23 UPDATE 1-Pharmacy chains should pay $878 mln for opioid epidemic role, Ohio counties say 2022-05-10 16:05:09 UPDATE 2-Major U.S. retailers limit infant formula purchases on shortage 2022-05-10 16:01:43 UPDATE 1-Major U.S. retailers limit baby formula purchases on shortage 2022-05-10 13:05:11 Baby formula shortage forces CVS Health to limit purchases 2022-05-10 12:07:01 REUTERS NEWS SCHEDULE AT 10 p.m. GMT/6 a.m. SGT 2022-05-08 22:00:53 CORRECTED-U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 16:14:57 U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 11:00:00 UPDATE 4-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 14:55:44 UPDATE 3-Walgreens reaches $683 mln opioid settlement with Florida 2022-05-05 13:50:14
14	Anthem Inc ORD ANTM.K	2.3% (+8.4%) (-6.2%) (+26.4%)	8 (8) News Stories UPDATE 2-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 12:14:42 UPDATE 1-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 10:35:49 BRIEF-Anthem CFO Says Omicron Surge Dissipated Faster Than Expected 2022-04-20 13:45:33 Anthem raises profit forecast on Medicaid boost 2022-04-20 10:24:16 BRIEF-Anthem Reports First Quarter 2022 Results, Reflecting Strong Momentum Across All Divisions 2022-04-20 10:23:12 UPDATE 1-Anthem raises profit forecast on Medicaid boost 2022-04-20 10:16:57 Health insurer Anthem's quarterly profit rises 8.4% 2022-04-20 10:15:27 Health insurer Anthem's quarterly profit rises 8.4% 2022-04-20 10:03:39
15	Intuitive Surgical Inc ORD ISRG.O	2.1% (-22.2%) (-23.6%) (-17.3%)	(0) News Stories
16	Stryker Corp ORD SYK	1.7% (-7.9%) (-13.5%) (-5.4%)	(0) News Stories
17	Zoetis Inc ORD ZTS	1.7% (-14.7%) (-11.4%) (-2.2%)	(0) News Stories
18	Cigna Corp ORD CI	1.5% (+18.5%) (+0.9%) (+3.1%)	13 (13) News Stories Arkansas sues drugmakers, pharmacy benefit managers over insulin costs 2022-05-11 17:22:01 Marketmind: How far behind the curve exactly? 2022-05-09 07:08:32 CORRECTED-U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 16:14:57 UPDATE 3-Health insurer Cigna boosts forecast as COVID costs recede 2022-05-06 14:53:57 BRIEF-Cigna Says Total Revenues In Q1 Were $44.0 Billion, Adjusted Revenue Were $44.1 Billion 2022-05-06 12:27:09 UPDATE 2-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 12:14:42 U.S. elections may thwart Democratic effort to cap insulin cost 2022-05-06 11:00:00 UPDATE 1-Cigna reports Q1 profit beat on health services unit strength 2022-05-06 10:35:49 Marketmind: Sell everything (except the dollar)! 2022-05-06 07:01:05 BRIEF-Cigna Corp - On April 28, Entered Into Three Separate Revolving Credit Facilities - Filing 2022-04-29 21:58:00 UPDATE 2-UnitedHealth to sell Change Healthcare's claims business for $2.2 bln 2022-04-25 15:49:42 UPDATE 1-UnitedHealth to sell Change Healthcare's claims business for $2.2 bln 2022-04-25 13:57:39 Cigna's Evernorth unit partners with rival Kaiser Permanente 2022-04-19 20:45:01
19	Becton Dickinson and Co ORD BDX	1.5% (-5.5%) (-4.3%) (+5.8%)	(0) News Stories
20	Gilead Sciences Inc ORD GILD.O	1.4% (+3.0%) (+0.6%) (-8.5%)	14 (14) News Stories BRIEF-FDA Lifts Clinical Hold On Investigational Lenacapavir For Treatment And Prevention Of HIV 2022-05-16 20:13:29 RPT-New class of cancer drugs down, not out, after Roche trial setback - analysts 2022-05-12 06:00:00 New class of cancer drugs down, not out, after Roche trial setback - analysts 2022-05-11 18:28:44 UPDATE 2-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 07:39:22 UPDATE 1-Blow to Roche's cancer immunotherapy prospects as 2nd trial fails 2022-05-11 06:16:46 Former Immunomedics CFO indicted for insider trading over tips to girlfriend 2022-05-10 22:11:03 BRIEF-Australia's TGA Says It Granted Provisional Approval To Gilead To Extend Use Of COVID-19 Treatment 2022-05-06 08:14:19 J&J sues to block sales of 'dangerous' counterfeit HIV drugs 2022-04-26 22:16:38 UPDATE 1-U.S. to widen COVID antiviral pill distribution 2022-04-26 12:35:46 UPDATE 1-U.S. FDA approves Gilead's COVID-19 drug for young children 2022-04-25 18:20:21 BRIEF-FDA Approves Covid-19 Treatment Veklury For Young Children 2022-04-25 18:04:31 BRIEF-Gilead Says Several New Studies Presented At Eccmic 2022 Confirm Veklury® (Remdesivir) Activity In Treating Covid-19 2022-04-24 22:11:19 WHO backs Pfizer's oral COVID therapy for high-risk patients 2022-04-21 22:01:00 BRIEF-Kite Gets U.S. FDA Approval Of CAR T-Cell Therapy Manufacturing Facility 2022-04-19 12:22:23

1 - 10 of 20

Top Sectors

	89% Health Care
	5% Industrials
	4% Consumer Services
	2% Remainder

Latest News for XLV Holdings

1:04pm EDT PFE	REFILE-U.S. to study whether longer Paxlovid course needed to combat reinfections (Fixes typographical error in third paragraph)</p> By Michael Erman> May 18 (Reuters) - The U.S. National Institutes of Health is in talks with Pfizer Inc ab...
12:20pm EDT PFE	UPDATE 1-As COVID cases rise, U.S. health officials mull widening additional booster eligibility (Recasts with expanding booster eligibility, adds quotes) By Ahmed Aboulenein and Jeff Mason WASHINGTON, May 18 (Reuters) - Health officials are conside...
10:29am EDT PFE	BRIEF-EMA Starts Evaluating Application For Use Of Booster Dose Of Comirnaty In Children Aged 5-11 Years May 18 (Reuters) - EMA: * EMA: EMA STARTED EVALUATING AN APPLICATION FOR THE USE OF A BOOSTER DOSE OF PFIZER/BIONTECH'S COVID-19 VACCINE, COMIRNATY, IN...
3:00am EDT JNJ PFE	INSIGHT-When Africans asked for COVID shots, they didn't get them. Now they don't want them * Demand for COVID shots drops in Africa as supply rises * Countries turn to mobile campaigns to boost uptake * Africa, average age 20, has fared better...
2:56am EDT PFE	From storage to transport, hurdles to getting COVID vaccine to N.Koreans By Soo-hyang Choi <p>SEOUL, May 18 (Reuters) - As North Korea battles its first known COVID outbreak, a lack of storage, chronic power shortages and inade...
6:12pm EDT MRK PFE	UPDATE 3-As U.S. COVID-19 cases rise, so does demand for antivirals (Recasts with rising cases, adds expert quotes) By Ahmed Aboulenein WASHINGTON, May 17 (Reuters) - Rising COVID-19 cases are driving up the use of thera...
4:34pm EDT ABT	UPDATE 3-U.S. Democrats unveil bill to address baby formula shortage (Adds comment from news conference) By Chris Gallagher WASHINGTON, May 17 (Reuters) - U.S. House Democrats on Tuesday unveiled a bill to provide $28 mil...
4:09pm EDT MRK PFE	UPDATE 2-U.S. says use of Pfizer's COVID-19 antiviral up 315% (Adds quotes, antiviral supply data, COVID-19 data, background) By Ahmed Aboulenein WASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral ant...
2:40pm EDT MRK PFE	U.S. use of Pfizer's COVID antiviral Paxlovid up 315% -HHS WASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Depar...
1:13pm EDT ABT	TIMELINE-Baby formula crunch in U.S. forces scramble to boost supplies May 17 (Reuters) - The nationwide shortage of baby formula has prompted the United States to temporarily allow foreign imports from other suppliers, w...

Health Care Select Sector SPDR (XLV)

At A Glance

Price

128.04USD

Category

YTD Return (Cumulative)

Classification

3 Year Return (Annualized)

52 Week High

52 Week Low

Lipper Leader Profile (Overall)

Holdings Diversification »

Asset Class

Key Statistics

Fund Characteristics

Geographic Exposure

Country Exposure

Top Holdings (as of Mar 31, 2022)

Market Cap

Concentration

(13) News Stories

(20) News Stories

(20) News Stories

(16) News Stories

(4) News Stories

(12) News Stories

(20) News Stories

(20) News Stories

(2) News Stories

(14) News Stories

(5) News Stories

(7) News Stories

(20) News Stories

(8) News Stories

(0) News Stories

(0) News Stories

(0) News Stories

(13) News Stories

(0) News Stories

(14) News Stories

Top Sectors

Latest News for XLV Holdings